Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Serine for Hereditary Sensory Neuropathy Type 1
NCT01733407Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-serine in Hereditary Sensory And Autonomic Neuropathy Type I, sponsored by Massachusetts General Hospital. Started Sep 2013; status: completed.
02
Drugs
l-serine
03
Conditions
Hereditary Sensory And Autonomic Neuropathy Type I
Beyond the preview
Go deeper on NCT01733407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733407.